Skip to content
askbio-logo Clinical Trials
  • Careers
  • News
  • Contact
  • Clinical Trials
  • For Patients
    • For Patients
    • Diseases
    • Clinical Trials
    • Patient Stories
    • Advocacy Partners
  • Our Focus
    • Genetic Diseases
    • AAV Gene Therapy
    • Pipeline
    • Research Areas
  • For Researchers
    • Discovery Program
    • Science & Technology
    • Partners & Collaborators
    • Resources
  • Our Technology
    • AAV Technology Platform
    • Capsids
    • Promoters
    • Pro10™
    • neDNA™
    • Manufacturing
  • About Us
    • Who we are
    • The Jude Samulski Story
    • Leadership Team
    • Board of Directors
    • Foundation
  • News
    • Careers
    • News
    • Contact
  • For Patients
    • For Patients
    • Diseases
    • Clinical Trials
    • Patient Stories
    • Advocacy Partners
  • Our Focus
    • Genetic Diseases
    • AAV Gene Therapy
    • Pipeline
    • Research Areas
  • For Researchers
    • Discovery Program
    • Science & Technology
    • Partners & Collaborators
    • Resources
  • Our Technology
    • AAV Technology Platform
    • Capsids
    • Promoters
    • Pro10™
    • neDNA™
    • Manufacturing
  • About Us
    • Who we are
    • The Jude Samulski Story
    • Leadership Team
    • Board of Directors
    • Foundation
  • News
    • Careers
    • News
    • Contact
  • Careers
  • News
  • Contact
  • Clinical Trials

About: mark

Posts by mark:

  • AskBio CEO and Co-Founder Sheila Mikhail Named One of the Fiercest Women in Life Sciences 2022 Posted on November 14, 2022 (November 18, 2022) by Mark Rosenberg in News
  • AskBio Co-Founder Jude Samulski Receives Inaugural European Society of Gene and Cell Therapy Founders Award Posted on October 28, 2022 (October 28, 2022) by Mark Rosenberg in News
  • AskBio Contribution to Advancing Gene Therapy Highlighted at ESGCT 29th Congress Posted on October 10, 2022 (October 10, 2022) by Mark Rosenberg in News&Uncategorized
  • AskBio Named One of Triangle’s Best Places to Work Posted on August 31, 2022 (August 31, 2022) by Mark Rosenberg in News
  • BrainVectis, a subsidiary of AskBio, receives clearance to conduct Phase I/II clinical trial in France for its novel gene therapy for early-stage Huntington’s Disease Posted on August 23, 2022 (August 23, 2022) by Mark Rosenberg in News&Uncategorized
  • AskBio Bolsters its Global Leadership Team with Two New Executives Posted on August 11, 2022 (August 11, 2022) by Mark Rosenberg in News
  • AskBio CEO and Co-Founder Sheila Mikhail receives 2022 Entrepreneurial Award  from University of Chicago Booth School of Business Posted on June 3, 2022 (June 3, 2022) by Mark Rosenberg in News
  • AskBio President of Therapeutics Dr. Katherine High receives Award from American Society of Gene and Cell Therapy  Posted on June 2, 2022 (June 2, 2022) by Mark Rosenberg in News&Uncategorized
  • AskBio to Present 11 Abstracts at Upcoming American Society of Gene and Cell Therapy’s 25th Annual Meeting  Posted on May 16, 2022 (June 2, 2022) by Mark Rosenberg in News&Uncategorized
  • Alliance for Regenerative Medicine (ARM) | 2020 Cell & Gene Therapies State of the Industry Posted on January 13, 2020 (January 28, 2020) by Mark Rosenberg in Event
  • «
  • 1
  • 2
  • 3
  • 4
  • …
  • 6
  • »
askbio-logo
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Inquiries

  • Media Center
  • Contact Us
  • Careers
  • Corporate Support

US Headquarters

20 T.W. Alexander Drive
Suite 110
Research Triangle Park,
NC 27709, USA

+1 (919) 561-6210

AskBio UK

Roslin Innovation Center
Easter Bush Campus
Edinburgh, EH25 9RG
Scotland

+44 (0) 131 651 9662

Mailing Address

PO Box 12848
Durham, NC 27709

© 2024 AskBio Inc. (AskBio)

  • Privacy and Terms
  • Terms and conditions of use